Deborah N. Coleman v. HHS - Influenza, Guillain-Barré syndrome (2023)
Case summary [AI summaries can sometimes make mistakes]
On May 19, 2020, Deborah N. Coleman filed a petition for compensation in the National Vaccine Injury Compensation Program.
Ms. Coleman alleged that she developed Guillain-Barré syndrome (GBS) as a result of receiving an influenza vaccination on October 14, 2016.
The respondent filed a report on July 7, 2021, stating that Ms. Coleman met the criteria set forth in the Vaccine Injury Table and Qualifications and Aids to Interpretation.
These criteria provide a presumption of causation for GBS following a seasonal flu vaccination within a specific timeframe, provided there is no apparent alternative cause. The respondent also indicated that Ms.
Coleman's injury was sufficiently severe, with residual effects lasting more than six months after the vaccination. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses.
Based on the respondent's recommendation and a review of the record, Special Master Thomas L. Gowen ruled that Ms.
Coleman is entitled to compensation. The case was then to proceed to the damages phase.
Elizabeth M. Muldowney represented the petitioner, and Nancy Tinch represented the respondent.
The ruling was issued on July 7, 2021.